Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Non-Small Cell Lung Cancer × Gemcitabine × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 328 Carcinoma, Non-Small-Cell Lung 163 Neoplasms 93 Breast Neoplasms 90 Lung Neoplasms 76 Urinary Bladder Neoplasms 68 Neoplasm Metastasis 62 Ovarian Neoplasms 47 Lymphoma 35 Cholangiocarcinoma 34 Sarcoma 32 Gallbladder Neoplasms 30 Biliary Tract Neoplasms 30 Hodgkin Disease 27 Adenocarcinoma 26 Lymphoma, Non-Hodgkin 24 Lymphoma, Large B-Cell, Diffuse 22 Unspecified Adult Solid Tumor, Protocol Specific 21 Fallopian Tube Neoplasms 21 Colorectal Neoplasms 21 Bile Duct Neoplasms 20 Urethral Neoplasms 19 Triple Negative Breast Neoplasms 19 Carcinoma, Transitional Cell 18 Carcinoma, Ovarian Epithelial 18 Recurrence 17 Carcinoma 17 Adenocarcinoma of Lung 15 Small Cell Lung Carcinoma 13 Carcinoma, Renal Cell 13

Interventions

lorlatinib 1 S 1 (combination) 1 Gemcitabine 1 Docetaxel 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00330746 2012-05-18

CALC-1

National Cancer Institute, Naples

Phase 2 Completed

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡